Investors NYSE AMERICAN: LCTX Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases November 09, 2023 Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update November 01, 2023 Lineage Cell Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on November 9, 2023 October 24, 2023 RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at Eyecelerator at 2023 American Academy of Ophthalmology (AAO) Annual Meeting VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics Corporate Overview November 9, 2023 6.6 MB 23rd EURETINA Congress Presentation 1.4 MB Roche’s Pharma Day 2023 Presentation 12.5 MB Third Quarter 2023 Financial Results Earnings Call Nov 9, 2023 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
November 09, 2023 Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
November 01, 2023 Lineage Cell Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on November 9, 2023
October 24, 2023 RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at Eyecelerator at 2023 American Academy of Ophthalmology (AAO) Annual Meeting
